JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Abstract Details

Activity Number: 298
Type: Contributed
Date/Time: Tuesday, July 31, 2012 : 8:30 AM to 10:30 AM
Sponsor: Biopharmaceutical Section
Abstract - #306505
Title: On Bayesian Design and Analysis for Trials with Multiple Primary Endpoints
Author(s): Kimberly Crimin*+ and Robb J Muirhead
Companies: Novartis and
Address: One Health Plaza, East Hanover, NJ, 07936, United States
Keywords: Bayesian ; multiple endpoints ; sample size

Many diseases are characterized by multiple co-primary endpoints and regulatory agencies require that efficacy be demonstrated on all of the endpoints for the drug to be efficacious. We present a Bayesian approach which incorporates information from a study to help size a new study which will use the same multiple co-primary endpoints. The approach is based on the joint posterior distribution of all the co-primary endpoints. The Bayesian approach incorporates correlations among the co-primary endpoints through the sample covariance matrix. We focus on conjugate prior distributions that are appropriate for multivariate normal models. We discuss considerations that should be taken into account in sample sizing problems and highlight the differences between Bayesian and frequentist approaches. We present results from a simulation study and illustrate the approach with an example.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2012 program

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.